CSL Ltd., Australia’s biggest pharmaceutical company, said it will buy back 950 million Australian dollars (US$827 million) of its own shares over the next year.
from WSJ.com: US Business http://ift.tt/1qqk9Kh
via IFTTT
from WSJ.com: US Business http://ift.tt/1qqk9Kh
via IFTTT
No comments:
Post a Comment